brl-301
Cell therapyexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 17, 2023 (NCT05859997)
Timeline
No events for the selected filters.
Mechanism of action
- Glycerol-3-phosphate dehydrogenaseImmunity, passive
GPD1 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07248163 | N/A | Mar 11, 2025 | Shanghai Bioray Laboratory Inc., Tongji University |
| NCT05988216 | N/A | Sep 30, 2023 | Shanghai Bioray Laboratory Inc., Zhejiang University |
| NCT05859997 | N/A | May 17, 2023 | Second Military Medical University, Shanghai Bioray Laboratory Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Bioray Laboratory Inc. | For profit | 3 | 3 | 1 | 2023 |
| Second Military Medical University | Government | 1 | 0 | 1 | 2023 |
| Tongji University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1